title: Anterior pelvic organ prolapse repair using synthetic mesh.
abstract: Since the U.S. Food and Drug Administration (FDA) statement on mesh in July of 2011, there has been controversy regarding synthetic mesh repairs for vaginal prolapse. In this article, we review the biochemical basis for the use of synthetic mesh in prolapse repair as well as clinical results of anterior compartment prolapse repair with synthetic mesh. Finally, we discuss the FDA warning regarding mesh.
authors.affiliation: Department of Urology, Virginia Mason Medical Center, Seattle, WA 98101, USA. bhavin.patel@vmmc.org
authors.forename: Bhavin N
authors.initials: BN
authors.lastname: Patel
authors.forename: Alvaro
authors.initials: A
authors.lastname: Lucioni
authors.forename: Kathleen C
authors.initials: KC
authors.lastname: Kobashi
mesh_terms: D005260:Female; D013509:Gynecologic Surgical Procedures / Q000009:adverse effects / Q000379:methods*; D006801:Humans; D017060:Patient Satisfaction; D056887:Pelvic Organ Prolapse / Q000601:surgery*; D012008:Recurrence; D013526:Surgical Mesh / Q000009:adverse effects; D016896:Treatment Outcome; D014481:United States; D014486:United States Food and Drug Administration; D014596:Uterine Prolapse / Q000601:surgery